Literature DB >> 15846277

Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction.

Rajesh Janardhanan1, James C C Moon, Dudley J Pennell, Roxy Senior.   

Abstract

BACKGROUND: Both myocardial contrast echocardiography (MCE) and cardiovascular magnetic resonance (CMR) can identify myocardial necrosis after acute myocardial infarction (AMI). However, transmural extent of infarction (TEI) correlates of myocardial perfusion by MCE after AMI are unknown. We sought to ascertain the ability of MCE to (1) predict TEI as defined by contrast-enhanced CMR and (2) to compare the relative accuracy of these techniques to predict contractile reserve late after AMI.
METHODS: MCE and CMR were performed in 42 patients with AMI 7 to 10 days after thrombolysis. Contractile reserve with low-dose dobutamine was evaluated 12 weeks after revascularization.
RESULTS: Both qualitative (myocardial contrast intensity) and quantitative MCE [peak contrast intensity, microbubble velocity (beta), and myocardial blood flow] showed a significant (P < .0001) inverse relationship with increasing TEI. However, beta was the single best predictor of TEI (P = .002). Both qualitative MCE and CMR predicted contractile reserve similarly (area under receiver operating characteristic curve were 0.84 and 0.80, respectively). Qualitative and quantitative MCE parameters as well as CMR correlated significantly with the degree of contractile reserve (P < .001). Multiple logistic regression analysis using clinical, electrocardiographic, MCE, and CMR parameters showed that both MCE (OR = 0.03, 95% CI 0.01-0.10, P < .001) and CMR (OR = 0.11, 95% CI 0.04-0.26, P < .001) are independent predictors of contractile reserve. The most discriminative quantitative parameters for prediction of contractile reserve were microbubble velocity (P < .001) and myocardial blood flow (P = .001) assessed by MCE.
CONCLUSION: MCE reflects the transmural extent of AMI as assessed by CMR. Both techniques predict contractile reserve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846277     DOI: 10.1016/j.ahj.2004.06.018

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  The role of cardiac ultrasound in stem cell therapy.

Authors:  Andrew M Kahn; Anthony N Demaria
Journal:  J Cardiovasc Transl Res       Date:  2009-01-22       Impact factor: 4.132

Review 2.  Prognosis following acute myocardial infarction: insights from cardiovascular magnetic resonance.

Authors:  Kevin J Duffy; Victor A Ferrari
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

Review 3.  Contrast echocardiography: an update.

Authors:  Rajesh K Chelliah; Roxy Senior
Journal:  Curr Cardiol Rep       Date:  2009-05       Impact factor: 2.931

Review 4.  Myocardial perfusion imaging with contrast echocardiography.

Authors:  Chad L Carr; Jonathan R Lindner
Journal:  Curr Cardiol Rep       Date:  2008-05       Impact factor: 2.931

Review 5.  Contrast echocardiography for detection of myocardial perfusion abnormalities : A clinical perspective.

Authors:  N Karogiannis; R Senior
Journal:  Herz       Date:  2017-05       Impact factor: 1.443

Review 6.  Assessment of myocardial perfusion with real-time myocardial contrast echocardiography: methodology and clinical applications.

Authors:  Abdou Elhendy; Thomas R Porter
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

7.  Limitations and potential clinical application on contrast echocardiography.

Authors:  Elisa Modonesi; Manrico Balbi; Gian Paolo Bezante
Journal:  Curr Cardiol Rev       Date:  2010-02

8.  Myocardial viability: what we knew and what is new.

Authors:  Adel Shabana; Ayman El-Menyar
Journal:  Cardiol Res Pract       Date:  2012-09-05       Impact factor: 1.866

Review 9.  A primer on the methods and applications for contrast echocardiography in clinical imaging.

Authors:  Sang-Hoon Seol; Jonathan R Lindner
Journal:  J Cardiovasc Ultrasound       Date:  2014-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.